CIK 0001681087
- Non-accelerated filer
- Smaller reporting company
Tectonic Therapeutic, Inc.
Sign in to watch- Ticker
- TECX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- Operating
- EIN
- 810710585
- Phone
- +1 339-666-3320
- Business address
- 490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
- Former names
- AvroBio, Inc., AVROBIO, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,920
- in 2 filings, $14K under 10b5-1 plans
Net −$13,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-08 | Avruch Steven Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +169,500 | 169,500 | ||
| 2022-06-08 | PAIGE CHRISTOPHER Director | Grant or award · Stock Option (Right to Buy) | +17,478 | 17,478 | ||
| 2022-06-08 | PAIGE CHRISTOPHER Director | Grant or award · Stock Option (Right to Buy) | +17,478 | 17,478 | ||
| 2022-06-08 | Donenberg Phillip B. Director | Grant or award · Stock Option (Right to Buy) | +17,478 | 17,478 | ||
| 2022-06-08 | Donenberg Phillip B. Director | Grant or award · Stock Option (Right to Buy) | +17,478 | 17,478 | ||
| 2022-06-08 | CLARK IAN T Director | Grant or award · Stock Option (Right to Buy) | +17,478 | 17,478 | ||
| 2022-06-08 | CLARK IAN T Director | Grant or award · Stock Option (Right to Buy) | +17,478 | 17,478 | ||
| 2022-06-08 | Vickers Philip J. Director | Grant or award · Stock Option (Right to Buy) | +17,478 | 17,478 | ||
| 2022-06-08 | Vickers Philip J. Director | Grant or award · Stock Option (Right to Buy) | +17,478 | 17,478 | ||
| 2022-06-08 | Farfel Gail M Director | Grant or award · Stock Option (Right to Buy) | +17,478 | 17,478 | ||
| 2022-06-08 | Farfel Gail M Director | Grant or award · Stock Option (Right to Buy) | +17,478 | 17,478 | ||
| 2022-06-08 | Jenkins Annalisa Director | Grant or award · Stock Option (Right to Buy) | +17,478 | 17,478 | ||
| 2022-06-08 | Jenkins Annalisa Director | Grant or award · Stock Option (Right to Buy) | +17,478 | 17,478 | ||
| 2022-06-08 | Booth Bruce Director | Grant or award · Stock Option (Right to Buy) | +17,478 | 17,478 | ||
| 2022-06-08 | Booth Bruce Director | Grant or award · Stock Option (Right to Buy) | +17,478 | 17,478 | ||
| 2022-02-02 | Petersen Deanna M Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-02-02 | Petersen Deanna M Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2022-02-02 | MACKAY GEOFFREY President & CEO | Grant or award · Stock Option (Right to Buy) | +405,000 | 405,000 | ||
| 2022-02-02 | MACKAY GEOFFREY President & CEO | Grant or award · Stock Option (Right to Buy) | +328,500 | 328,500 | ||
| 2022-02-02 | Ridha Essra Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 |
Page 11 of 17 · 322 trades